Lifestyle coaching may be key to keeping weight off after stopping obesity drugs
NCT ID NCT05608226
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study tests whether a remotely delivered lifestyle education program can help people who have lost weight with medication keep that weight off after they stop taking the drugs. Participants are adults who lost at least 5% of their body weight during a previous pharmacotherapy trial. The program focuses on healthy eating, physical activity, and behavior change, and the study tracks weight, blood lipids, blood sugar, and blood pressure over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifestyle Education Program
- What this could lead to
- If successful, this could show that a structured lifestyle program helps people keep weight off after stopping weight-loss drugs.
- What could go wrong
- This is a small, early-stage study in Chinese adults only, so results may not apply to other groups. Lifestyle adherence can be challenging, and weight regain may still occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BODY-WEIGHT TRAJECTORY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xiaoying Li
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test